Gossamer Bio, Inc. (GOSS) Net income 2017–2025
Gossamer Bio, Inc. (GOSS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$170.4MFY2025 · since FY2017: -$6.8M → -$170.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$170.4M | -201.4% |
| FY2024 | -$56.5M | +68.6% |
| FY2023 | -$179.8M | +21.6% |
| FY2022 | -$229.4M | +2.0% |
| FY2021 | -$234.0M | +3.8% |
| FY2020 | -$243.4M | -35.0% |
| FY2019 | -$180.3M | -22.7% |
| FY2018 | -$147.0M | -2070.6% |
| FY2017 | -$6.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice